Pharmaceutical

AstraZeneca’s Truqap and Faslodex combo receives approval in EU

AstraZeneca has received approval for Truqap in combination with Faslodex in the EU to treat certain advanced breast cancer cases in adults.

Jun 22, 2024 - 04:00
AstraZeneca’s Truqap and Faslodex combo receives approval in EU
AstraZeneca has received approval for Truqap in combination with Faslodex in the EU to treat certain advanced breast cancer cases in adults.
Read the original article

Tags:

Previous Article

Sanofi and Biovac partner to produce polio vaccines in Africa

Next Article

Will WHO’s new guidance spur hepatitis B immunisation?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CHMP provides positive opinion for BMS’s Reblozyl

CHMP provides positive opinion for BMS’s Reblozyl

Feb 24, 2024

Santhera fully divests rare eye disease drug Raxone to Chiesi

Santhera fully divests rare eye disease drug Raxone to ...

Jul 31, 2023

Labcorp forms spin-off of Fortrea

Labcorp forms spin-off of Fortrea

Jul 5, 2023